{"api":"v1","generatedAt":"2026-09-03T15:58:23.839Z","edition":"Serbia of Tomorrow","domain":"serbiaoftomorrow.com","view":"company/tomasevic-dren-bio-sanofi","page":"https://serbiaoftomorrow.com/map/company/tomasevic-dren-bio-sanofi/","node":{"id":"company/tomasevic-dren-bio-sanofi","kind":"company","slug":"tomasevic-dren-bio-sanofi","label":"Dren Bio","sub":"Nenad Tomašević","href":"/founder/tomasevic-dren-bio-sanofi/","mapHref":"/map/company/tomasevic-dren-bio-sanofi/","cardNo":2,"category":"Diaspora","sector":"sector/diaspora","tone":"diaspora","moved":"2026-07-16","entered":"2026-07-04","recentMoved":false,"recentEntered":false,"sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"v":3,"sha256":"43cd6c67bb13e866825ee3004216c72713f1e54c2c9e73c6a9d1fe88b2cbf0fa","anchoredAt":"2026-07-16T14:49:39.943Z","proofHref":"/proof/tomasevic-dren-bio-sanofi/","historyHref":"/founder/tomasevic-dren-bio-sanofi/history/","facts":[{"id":"company-name","kind":"company-name","value":{"name":"Dren Bio"},"provenance":{"method":"card","sourceText":"Dren Bio","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"founder-name","kind":"founder-name","value":{"name":"Nenad Tomašević"},"provenance":{"method":"card","sourceText":"Nenad Tomašević","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"founded","kind":"founded","value":{"year":2019,"city":"Bay Area  California"},"provenance":{"method":"card","sourceText":"2019 · Bay Area, California","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"round-2019-seed","kind":"round","value":{"amount":6000000,"currency":"USD","approx":false,"stage":"seed","year":2019,"text":"$6M seed 2019"},"provenance":{"method":"card","sourceText":"$6M seed 2019","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"round-2022-series-b","kind":"round","value":{"amount":65000000,"currency":"USD","approx":false,"stage":"series-b","year":2022,"text":"$65M Series B 2022"},"provenance":{"method":"card","sourceText":"$65M Series B 2022","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"raised-total","kind":"raised-total","value":{"amount":156000000,"currency":"USD","approx":true,"text":"$156M+ total ($6M seed 2019, $65M Series B 2022)"},"provenance":{"method":"card","sourceText":"$156M+ total ($6M seed 2019, $65M Series B 2022)","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"exit","kind":"unparsed","value":{"field":"exit","text":"$600M upfront, Sanofi 2025"},"provenance":{"method":"card","sourceText":"$600M upfront, Sanofi 2025","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"unparsed"},{"id":"backer-8vc","kind":"backer","value":{"firm":"8VC","canonical":"8VC","note":""},"provenance":{"method":"card","sourceText":"8VC","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"backer-aisling-capital","kind":"backer","value":{"firm":"Aisling Capital","canonical":"Aisling Capital","note":""},"provenance":{"method":"card","sourceText":"Aisling Capital","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"backer-hbm-healthcare-investments","kind":"backer","value":{"firm":"HBM Healthcare Investments","canonical":"HBM Healthcare Investments","note":""},"provenance":{"method":"card","sourceText":"HBM Healthcare Investments","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"},{"id":"backer-pfizer","kind":"backer","value":{"firm":"Pfizer","canonical":"Pfizer","note":""},"provenance":{"method":"card","sourceText":"Pfizer","sources":[{"text":"Dren Bio team page (Nenad Tomašević official biography)","url":"https://www.drenbio.com/team.html"},{"text":"Sanofi press release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager (March 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-20-06-00-00-3045945"},{"text":"Sanofi press release: Sanofi completes acquisition of DR-0201 (May 2025)","url":"https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-27-05-00-00-3088324"},{"text":"BusinessWire: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025)","url":"https://www.businesswire.com/news/home/20251215349902/en/Dren-Bio-Expands-Strategic-Collaboration-with-Sanofi-to-Develop-Next-Generation-B-Cell-Depletion-Therapy"},{"text":"BusinessWire: Dren Bio Announces Strategic Collaboration with Novartis (July 2024)","url":"https://www.businesswire.com/news/home/20240724830878/en/Dren-Bio-Announces-Strategic-Collaboration-with-Novartis-to-Develop-Novel-Targeted-Myeloid-Engagers-for-Cancer"},{"text":"BusinessWire: Dren Bio Announces $65 Million Series B Financing (June 2022)","url":"https://www.businesswire.com/news/home/20220614005372/en/Dren-Bio-Announces-65-Million-Series-B-Financing-to-Advance-its-Lead-Asset-into-the-Clinic-and-to-Accelerate-Development-of-New-Product-Candidates-from-its-Targeted-Myeloid-Engager-and-Phagocytosis-Platform"},{"text":"FierceBiotech: Sanofi pens $1.9B deal for Dren Bio's bispecific (March 2025)","url":"https://www.fiercebiotech.com/biotech/sanofi-pens-19b-deal-dren-bios-bispecific-latest-immunology-play"},{"text":"FierceBiotech: Novartis hopes for better luck with bispecifics via $150M Dren Bio deal (July 2024)","url":"https://www.fiercebiotech.com/biotech/new-growth-novartis-pharma-announces-partnership-dren-bio"},{"text":"SeeNews: Sanofi to buy immunology drug from Serbian-founded Dren Bio","url":"https://seenews.com/news/sanofi-to-buy-immunology-drug-from-serbian-founded-dren-bio-1272640"},{"text":"CORD Magazine: Nenad Tomašević, CEO Dren Bio Inc. Interview","url":"https://cordmagazine.com/country-in-focus/usa/nenad-tomasevic-ceo-dren-bio-lets-copy-ourselves-and-others/"},{"text":"Crunchbase: Nenad Tomasevic profile","url":"https://www.crunchbase.com/person/nenad-tomasevic"},{"text":"The Recursive: Biggest Funding Rounds for Serbian Startups in 2025","url":"https://therecursive.com/biggest-funding-rounds-for-serbian-startups-in-2025/"},{"text":"BioSpace: Dren Bio announces a $60M Series A financing (October 2020; states the $6M 2019 seed led by 8VC)","url":"https://www.biospace.com/dren-bio-announces-a-60m-series-a-financing"},{"text":"BioSpace: Dren Bio Expands Strategic Collaboration with Sanofi (December 2025; $100M upfront, up to $1.7B milestones)","url":"https://www.biospace.com/press-releases/dren-bio-expands-strategic-collaboration-with-sanofi-to-develop-next-generation-b-cell-depletion-therapy"}],"checkedAt":"2026-09-03","checkedBy":"extractor@1"},"status":"source-checked"}]},"first":[{"id":"firm/8vc","kind":"firm","slug":"8vc","label":"8VC","sub":"","href":"/investors/","mapHref":"/map/firm/8vc/","records":1,"page":false,"type":null,"hq":null,"tone":"diaspora"},{"id":"firm/aisling-capital","kind":"firm","slug":"aisling-capital","label":"Aisling Capital","sub":"","href":"/investors/","mapHref":"/map/firm/aisling-capital/","records":1,"page":false,"type":null,"hq":null,"tone":"diaspora"},{"id":"firm/hbm-healthcare-investments","kind":"firm","slug":"hbm-healthcare-investments","label":"HBM Healthcare Investments","sub":"","href":"/investors/","mapHref":"/map/firm/hbm-healthcare-investments/","records":1,"page":false,"type":null,"hq":null,"tone":"diaspora"},{"id":"firm/pfizer","kind":"firm","slug":"pfizer","label":"Pfizer","sub":"","href":"/investors/","mapHref":"/map/firm/pfizer/","records":1,"page":false,"type":null,"hq":null,"tone":"diaspora"},{"id":"sector/diaspora","kind":"sector","slug":"diaspora","label":"Diaspora","sub":"1 on the record","href":"/diaspora/","mapHref":"/map/sector/diaspora/","tone":"diaspora","count":1,"heat":{"d30":0,"d90":1,"d365":1}}],"second":[],"edges":[{"a":"firm/8vc","b":"company/tomasevic-dren-bio-sanofi","kind":"backed","prov":{"record":"tomasevic-dren-bio-sanofi","v":3,"sha256":"43cd6c67bb13e866825ee3004216c72713f1e54c2c9e73c6a9d1fe88b2cbf0fa","anchoredAt":"2026-07-16T14:49:39.943Z","proofHref":"/proof/tomasevic-dren-bio-sanofi/"}},{"a":"firm/aisling-capital","b":"company/tomasevic-dren-bio-sanofi","kind":"backed","prov":{"record":"tomasevic-dren-bio-sanofi","v":3,"sha256":"43cd6c67bb13e866825ee3004216c72713f1e54c2c9e73c6a9d1fe88b2cbf0fa","anchoredAt":"2026-07-16T14:49:39.943Z","proofHref":"/proof/tomasevic-dren-bio-sanofi/"}},{"a":"firm/hbm-healthcare-investments","b":"company/tomasevic-dren-bio-sanofi","kind":"backed","prov":{"record":"tomasevic-dren-bio-sanofi","v":3,"sha256":"43cd6c67bb13e866825ee3004216c72713f1e54c2c9e73c6a9d1fe88b2cbf0fa","anchoredAt":"2026-07-16T14:49:39.943Z","proofHref":"/proof/tomasevic-dren-bio-sanofi/"}},{"a":"firm/pfizer","b":"company/tomasevic-dren-bio-sanofi","kind":"backed","prov":{"record":"tomasevic-dren-bio-sanofi","v":3,"sha256":"43cd6c67bb13e866825ee3004216c72713f1e54c2c9e73c6a9d1fe88b2cbf0fa","anchoredAt":"2026-07-16T14:49:39.943Z","proofHref":"/proof/tomasevic-dren-bio-sanofi/"}},{"a":"company/tomasevic-dren-bio-sanofi","b":"sector/diaspora","kind":"in"},{"a":"firm/8vc","b":"firm/aisling-capital","kind":"co","weight":1,"shared":["company/tomasevic-dren-bio-sanofi"],"latest":"2026-07-16"},{"a":"firm/8vc","b":"firm/hbm-healthcare-investments","kind":"co","weight":1,"shared":["company/tomasevic-dren-bio-sanofi"],"latest":"2026-07-16"},{"a":"firm/8vc","b":"firm/pfizer","kind":"co","weight":1,"shared":["company/tomasevic-dren-bio-sanofi"],"latest":"2026-07-16"},{"a":"firm/aisling-capital","b":"firm/hbm-healthcare-investments","kind":"co","weight":1,"shared":["company/tomasevic-dren-bio-sanofi"],"latest":"2026-07-16"},{"a":"firm/aisling-capital","b":"firm/pfizer","kind":"co","weight":1,"shared":["company/tomasevic-dren-bio-sanofi"],"latest":"2026-07-16"},{"a":"firm/hbm-healthcare-investments","b":"firm/pfizer","kind":"co","weight":1,"shared":["company/tomasevic-dren-bio-sanofi"],"latest":"2026-07-16"}],"provenance":"Every backed edge carries the record version that states it (prov.v, prov.sha256, prov.anchoredAt); the version hash is anchored to Bitcoin and verifiable at prov.proofHref. Sources are on the company node."}